Trans-HHS Workshop : Diet , DNA Methylation Processes and Health Elevation in S-Adenosylhomocysteine and DNA Hypomethylation : Potential Epigenetic Mechanism for Homocysteine-Related Pathology 1

Chronic nutritional deficiencies in folate, choline, methionine, vitamin B-6 and/or vitamin B-12 can perturb the complex regulatory network that maintains normal one-carbon metabolism and homocysteine homeostasis. Genetic polymorphisms in these pathways can act synergistically with nutritional deficiencies to accelerate metabolic pathology associated with occlusive heart disease, birth defects and dementia. A major unanswered question is whether homocysteine is causally involved in disease pathogenesis or whether homocysteinemia is simply a passive and indirect indicator of a more complex mechanism. S-Adenosylmethionine and S-adenosylhomocysteine (SAH), as the substrate and product of methyltransferase reactions, are important metabolic indicators of cellular methylation status. Chronic elevation in homocysteine levels results in parallel increases in intracellular SAH and potent product inhibition of DNA methyltransferases. SAH-mediated DNA hypomethylation and associated alterations in gene expression and chromatin structure may provide new hypotheses for pathogenesis of diseases related to homocysteinemia. J. Nutr. 132: 2361S–2366S, 2002.

[1]  B. Mirkin,et al.  S-adenosylmethionine synthetase is overexpressed in murine neuroblastoma cells resistant to nucleoside analogue inhibitors of S-adenosylhomocysteine hydrolase: a novel mechanism of drug resistance. , 1999, Cancer research.

[2]  E. H. Willis,et al.  Selection and characterization of a murine lymphoid cell line partially deficient in S-adenosylhomocysteine hydrolase. , 1983, Biochimica et biophysica acta.

[3]  R. Borchardt,et al.  Pancreatic exocrine secretion is blocked by inhibitors of methylation. , 1997, Archives of biochemistry and biophysics.

[4]  J. Finkelstein,et al.  Pathways and Regulation of Homocysteine Metabolism in Mammals , 2000, Seminars in thrombosis and hemostasis.

[5]  I. Pogribny,et al.  Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. , 1998, The Journal of nutrition.

[6]  W. Haefeli,et al.  Disturbed ratio of erythrocyte and plasma S-adenosylmethionine/S-adenosylhomocysteine in peripheral arterial occlusive disease. , 2001, Atherosclerosis.

[7]  J. Finkelstein,et al.  The metabolism of homocysteine: pathways and regulation , 1998, European Journal of Pediatrics.

[8]  M. Bennett Reactive oxygen species and death: oxidative DNA damage in atherosclerosis. , 2001, Circulation research.

[9]  S. Vollset,et al.  Plasma total homocysteine and cardiovascular and noncardiovascular mortality: the Hordaland Homocysteine Study. , 2001, The American journal of clinical nutrition.

[10]  D. Marion,et al.  S-Adenosylmethionine and S-adenosylhomocystein metabolism in isolated rat liver. Effects of L-methionine, L-homocystein, and adenosine. , 1980, The Journal of biological chemistry.

[11]  J F Gregory,et al.  Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. , 1999, The Journal of nutrition.

[12]  P. Chiang,et al.  Induction of HL-60 cell differentiation by 3-deaza-(+/-)-aristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase. , 1986, Cancer research.

[13]  S. Ross,et al.  S-adenosylhomocysteine inhibition of three purified tRNA methyltransferases from rat liver. , 1975, Nucleic acids research.

[14]  S. J. James,et al.  Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation , 1996, Hepatology.

[15]  P. Chiang Biological effects of inhibitors of S-adenosylhomocysteine hydrolase. , 1998, Pharmacology & therapeutics.

[16]  J. Fernández-Piqueras,et al.  Molecular and cytological evidence of S-adenosyl-L-homocysteine as an innocuous undermethylating agent in vivo. , 1995, Cytogenetics and cell genetics.

[17]  G. Cantoni The role of S-adenosylhomocysteine in the biological utilization of S-adenosylmethionine. , 1985, Progress in clinical and biological research.

[18]  C. Rock,et al.  Nutrition, genetics, and risks of cancer. , 2000, Annual review of public health.

[19]  M. Hershfield,et al.  Basis for resistance to 3-deazaaristeromycin, an inhibitor of S-adenosylhomocysteine hydrolase, in human B-lymphoblasts. , 1989, The Journal of biological chemistry.

[20]  R. Cox,et al.  The effect of S-adenosylhomocysteine on DNA methylation in isolated rat liver nuclei. , 1977, Biochimica et biophysica acta.

[21]  Colin A. Johnson,et al.  Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex , 1998, Nature.

[22]  R. Surtees Demyelination and inborn errors of the single carbon transfer pathway , 1998, European Journal of Pediatrics.

[23]  C. Rudin,et al.  Signal transduction pathways that regulate cell survival and cell death , 1998, Oncogene.

[24]  R. Abeles,et al.  The mechanism of action of S-adenosylhomocysteinase. , 1979, The Journal of biological chemistry.

[25]  J. Barchas,et al.  Inhibition of transmethylations of biogenic amines by S-adenosylhomocysteine. Enhancement of transmethylation by adenosylhomocysteinase. , 1971, The Journal of biological chemistry.

[26]  I. Pogribny,et al.  Apoptosis and proliferation under conditions of deoxynucleotide pool imbalance in liver of folate/methyl deficient rats. , 1997, Carcinogenesis.

[27]  P. Chiang,et al.  The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes. , 1978, Biochemical and biophysical research communications.

[28]  M. Koury,et al.  Plasma S-adenosylhomocysteine is a more sensitive indicator of cardiovascular disease than plasma homocysteine. , 2001, The American journal of clinical nutrition.

[29]  D. Hoffman,et al.  Microsomal phosphatidylethanolamine methyltransferase: Inhibition by S-adenosylhomocysteine , 1981, Lipids.

[30]  P. Frosst,et al.  Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[31]  D. Kennedy,et al.  The relationship between the activity of methionine synthase and the ratio of S-adenosylmethionine to S-adenosylhomocysteine in the brain and other tissues of the pig. , 1992, Biochemical pharmacology.

[32]  T. Bottiglieri Folate, vitamin B12, and neuropsychiatric disorders. , 2009, Nutrition reviews.

[33]  D. Hoffman,et al.  Relationship between tissue levels of S-adenosylmethionine, S-adenylhomocysteine, and transmethylation reactions. , 1979, Canadian journal of biochemistry.

[34]  M. Briske-Anderson,et al.  Effect of adenosine metabolites on methyltransferase reactions in isolated rat livers. , 1981, Biochimica et biophysica acta.

[35]  V. Zappia,et al.  Metabolic consequences of folate-induced reduction of hyperhomocysteinemia in uremia. , 1997, Journal of the American Society of Nephrology : JASN.

[36]  N. Maeda,et al.  Endothelial Dysfunction and Elevation of S-Adenosylhomocysteine in Cystathionine &bgr;-Synthase–Deficient Mice , 2001, Circulation research.

[37]  D. Kennedy,et al.  Correlation of the ratio of S-adenosyl-L-methionine to S-adenosyl-L-homocysteine in the brain and cerebrospinal fluid of the pig: implications for the determination of this methylation ratio in human brain. , 1992, Clinical science.

[38]  R. Borchardt,et al.  Effects of S-adenosylhomocysteine analogues on vaccinia viral messenger ribonucleic acid synthesis and methylation. , 1982, Biochemistry.

[39]  I. Pogribny,et al.  Alterations in hepatic p53 gene methylation patterns during tumor progression with folate/methyl deficiency in the rat. , 1997, Cancer letters.

[40]  H. Cohen,et al.  The C677T MTHFR gene mutation is not predictive of risk for recurrent fetal loss , 1999, British journal of haematology.

[41]  M. Rudnicki,et al.  Mice deficient in methylenetetrahydrofolate reductase exhibit hyperhomocysteinemia and decreased methylation capacity, with neuropathology and aortic lipid deposition. , 2001, Human molecular genetics.

[42]  C. Culmsee,et al.  Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity , 2000, The Journal of Neuroscience.

[43]  T. Arinami,et al.  Methylenetetrahydrofolate reductase variant and schizophrenia/depression. , 1997, American journal of medical genetics.

[44]  J. Mason,et al.  Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[45]  R. Green,et al.  Homocysteine metabolism in cardiovascular cells and tissues: implications for hyperhomocysteinemia and cardiovascular disease. , 1999, Advances in enzyme regulation.

[46]  C. Ervin,et al.  The methylenetetrahydrofolate reductase 677C-->T polymorphism and distal colorectal adenoma risk. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[47]  T. Wilens,et al.  Decreased Transmethylation of Biogenic Amines After In Vivo Elevation of Brain S‐Adenosyl‐l‐Homocysteine , 1981, Journal of neurochemistry.

[48]  E. Haber,et al.  Inhibition of Growth and p21 ras Methylation in Vascular Endothelial Cells by Homocysteine but Not Cysteine* , 1997, The Journal of Biological Chemistry.

[49]  A. Mitchell Hypomethylation of human heterochromatin detected by restriction enzyme nick translation. , 1992, Experimental cell research.

[50]  P. Chiang Conversion of 3T3-L1 fibroblasts to fat cells by an inhibitor of methylation: effect of 3-deazaadenosine. , 1981, Science.

[51]  J. Vonsattel,et al.  DNA strand breaks in Alzheimer's disease , 1999, Brain Research.

[52]  R. Borchardt,et al.  Affinity labeling of histamine N-methyltransferase by 2',3'-dialdehyde derivatives of S-adenosylhomocysteine and S-adenosylmethionine. Kinetics of inactivation. , 1978, Biochemistry.

[53]  D. Kennedy,et al.  Effects of the disruption of transmethylation in the central nervous system: an animal model , 1994, Acta neurologica Scandinavica. Supplementum.

[54]  P. Chiang,et al.  Phospholipids biosynthesis by methylations and choline incorporation: effect of 3-deazaadenosine. , 1980, Biochemical and biophysical research communications.

[55]  M. Peter,et al.  S-adenosylhomocysteine as a physiological modulator of Apo-1-mediated apoptosis. , 1996, International immunology.

[56]  L. Poirier,et al.  Breaks in genomic DNA and within the p53 gene are associated with hypomethylation in livers of folate/methyl-deficient rats. , 1995, Cancer research.

[57]  I. Pogribny,et al.  Intracellular S-adenosylhomocysteine concentrations predict global DNA hypomethylation in tissues of methyl-deficient cystathionine beta-synthase heterozygous mice. , 2001, The Journal of nutrition.

[58]  E. Kaminskas,et al.  Accumulation of DNA strand breaks and methotrexate cytotoxicity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Christman,et al.  Alterations in expression and methylation of specific genes in livers of rats fed a cancer promoting methyl-deficient diet. , 1991, Carcinogenesis.

[60]  A. Cimmino,et al.  Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: implications for mechanism. , 2001, Kidney international.

[61]  R. Blumenthal,et al.  S-adenosylmethionine-dependent methyltransferases : structures and functions , 1999 .

[62]  I. Pogribny,et al.  Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* , 2000, The Journal of Biological Chemistry.

[63]  P. Chiang,et al.  Perturbation of biochemical transmethylations by 3-deazaadenosine in vivo. , 1979, Biochemical pharmacology.

[64]  S. Vollset,et al.  The controversy over homocysteine and cardiovascular risk. , 2000, The American journal of clinical nutrition.

[65]  T. Eskes Neural tube defects, vitamins and homocysteine , 1998, European Journal of Pediatrics.